|
|
 |
PARADIGM™ Cartridge Applications Chart |
|
If you cannot locate a cartridge below that meets your application needs,
Beckman Coulter can create a
Custom Cartridge.
Download the PARADIGM Applications Chart (Excel .XLS, 52K)
| Application |
Label Detection/Method |
Ex |
Em |
PARADIGM™ Cartridge Type |
| Absorbance |
Multimode |
Fluorescence Intensity (cuom-fluor) |
Fluorescence Intensity (fluor-rhod) |
Fluorescence Intensity (Cy3-Cy5) |
Fluorescence Intensity (CFP-YFP) |
Fluorescence Intensity (GeneBLAzer) |
Fluorescence Polarization (fluorescein) |
Fluorescence Polarization (rhodamine) |
Time Resolved Fluorescence |
Cisbio HTRF |
LanthaScreen TR-FRET |
Luminescence |
Luminescence (chrom glo) |
Luminescence (BRET2) |
AlphaScreen |
Fluorescence Intensity Dual Label (Multi-Tox Fluor) |
| Apoptosis |
Annexin V conjugate |
div |
div |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Apo-ONE |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Caspase-Glo |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| EnzCheck caspase |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| TruPoint |
370 |
616 |
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
| cAMP Quant |
[FP]2™ cAMP |
div |
div |
|
|
|
|
|
|
|
X |
X |
|
|
|
|
|
|
|
|
| cAMP Chemiluminescence |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| EFC, HitHunter |
div |
div |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CatchPoint |
div |
div |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DELFIA cAMP |
370 |
616 |
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
| LANCE |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| AlphaScreen |
680 |
570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
|
DNA Quant, DNA Purity |
260, 280 nm
UV absorbance |
260, 280 |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DNA Quant, RNA Purity |
Hoechst |
360 |
465 |
|
X |
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oligreen
(Quant-iT™) |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
Picogreen
(Quant-iT™) |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ribogreen
(Quant-iT™) |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Genotyping |
SNP, AcycloPrime |
div |
div |
|
|
|
|
|
|
|
X |
X |
|
|
|
|
|
|
|
|
| GPCR |
DELFIA Assays |
370 |
616 |
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
| EFC, HitHunter |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| HTRF |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| LANCE |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| GTP Binding |
DELFIA Assays |
370 |
616 |
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
| Hormones |
17beta-Estradiol |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Cortisol |
405 (580) |
N/A |
X |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
| Immunoassays |
HRP-substrate PS-atto |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| AP-substrate |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| DELFIA assays |
370 |
616 |
|
X |
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
| ELISA |
div |
div |
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HTRF |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| Leukotriene B4 |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Substance P |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Thromboxane B2 |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Ion Channels |
Fluo-3,-4 |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| IP3 Quant |
AlphaScreen |
680 |
570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
|
| Kinase Activity |
EFC, HitHunter |
div |
div |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| ERK1/2 (phospho) |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| HTRF |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| HTRF |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| Adapta™ Universal Kinase Assay |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| IMAP |
div |
div |
|
|
|
|
|
|
|
X |
X |
|
|
|
|
|
|
|
|
| LANCE |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| LanthaScreen |
340 |
490, 520 |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
| Z´-Lyte |
406 |
465, 535 |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
| Molecular Interactions |
BRET2 |
N/A |
410, 535 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
| FP |
div |
div |
|
|
|
|
|
|
|
X |
X |
|
|
|
|
|
|
|
|
| FRET |
div |
div |
|
|
X |
X |
X |
X |
X |
|
|
|
|
|
|
|
|
|
X |
| GFP-RFP FRET |
485 |
535, 595 |
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cy3-Cy5 FRET |
535 |
595, 655 |
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
| CFP-YFP FRET |
445 |
485, 535 |
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
| GeneBLAzer |
406 |
465, 535 |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
| Nuclear Receptor |
AlphaScreen |
680 |
570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
|
| EFC, HitHunter |
div |
div |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| FP |
div |
div |
|
|
|
|
|
|
|
X |
X |
|
|
|
|
|
|
|
|
| LANCE |
320 |
616, 665 |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
| LanthaScreen |
340 |
490, 520 |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|
| Proliferation, viability, cytotoxicity |
Alamar Blue |
535 |
595 |
X |
X |
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
| CellTiter Blue |
535 |
595 |
|
X |
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
| MTS, XTT, MTT |
div |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MultiTox-Fluor |
406, 504 |
465, 542 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
| Prostaglandines |
6-keto PGF1alpha |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| PGE1 |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| PGE2 |
405 (580) |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Protease |
EFC, HitHunter |
div |
div |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Protein Analysis |
Thioflavin T |
445 |
585 |
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
| Protein Quant |
Bradford, BCA, Lowry |
div |
N/A |
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nanoorange (Quant-iT™) |
485 |
535 |
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reporter Assays |
Bright-Glo™ Luciferase Assay |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Steady-Glo® Luciferase Assay |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| Chroma-Glo™ Luciferase Assay |
N/A |
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
| Dual-Glo™ Luciferase Assay |
N/A |
N/A |
|
X |
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
| GFP |
485 |
535 |
|
X |
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| CFP |
445 |
485 |
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
| GeneBLAzer |
406 |
465, 535 |
|
|
|
|
|
|
X |
|
|
|
|
|
|
|
|
|
|
Cellular Pathway Assays |
LanthaScreen |
340 |
490, 520 |
|
|
|
|
|
|
|
|
|
|
|
X |
|
|
|
|
|

Additional Information:

|